Physician profile
Jason G Dalling
NPI 1689896433
$1,285.08
in general payments reported to CMS, 2019-2025
10 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $241 · 2021: $355 · 2022: $132 · 2023: $115 · 2024: $167 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $595.95 | 2019-2025 | Accolade, Biolox, Pangea |
| Zimmer Biomet Holdings, INC. | $398.53 | 2021-2022 | |
| Vericel Corporation | $93.32 | 2019-2023 | Maci |
| Boston Scientific Corporation | $62.51 | 2021-2024 | |
| Smith+Nephew, INC. | $46.57 | 2025 | Pico 7 |
| Active Medical, LLC | $25.26 | 2023 | |
| Linvatec Corporation | $21.06 | 2025 | Biobrace 23mm |
| Kci USA, INC. | $16.46 | 2023 | Prevena |
| Pacira Pharmaceuticals Incorporated | $13.90 | 2025 | Exparel, Iovera |
| Heron Therapeutics, INC. | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Dalling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.